Interestingly, CD4+ T lymphocytes further increased and were closer to epithelial or CD8+ T cells in CR patients after the IP, all signs of an activated and tumor-specific immune response that could have been directly fostered by ONCOFID-P-BTM action, as the HA mojety has intrinsic immunomodulatory effects. Here, CD8A is linked to neoplasm.